Form 8-K - Current report:
SEC Accession No. 0001193125-20-264807
Filing Date
2020-10-06
Accepted
2020-10-06 16:46:59
Documents
2
Period of Report
2020-10-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d17027d8k.htm 8-K 23870
2 EX-3.1 d17027dex31.htm EX-3.1 25684
  Complete submission text file 0001193125-20-264807.txt   50894
Mailing Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Filer) CIK: 0001662579 (see all company filings)

EIN.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39567 | Film No.: 201227242
SIC: 2836 Biological Products, (No Diagnostic Substances)